HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg
Status:
Unknown status
Trial end date:
2018-06-30
Target enrollment:
Participant gender:
Summary
Chronic HBV infection is major problem in Asian countries. Years after chronic infection, in
some cases serum HBsAg level declines to unmeasurable level. Some of patients develop
anti-HBsAb but there is no standard treatment to accelerate HBsAg seroconversion.
There is a study to determine efficacy and safety of HBV vaccine in who is Chronic HBV
infection and lost their HBsAg without seroconversion to anti-HBsAb.